PhaseBio Pharmaceuticals EV/FCF
EV/FCF of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart.
A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.